Wanyang Liu
Overview
Explore the profile of Wanyang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1067
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Zou Z, Liu W, Zhang Q, Shen J, Hao F, et al.
Eur J Neurol
. 2024 Sep;
31(12):e16473.
PMID: 39315749
Background And Purpose: The penetrance of the RNF213 p.R4810K, a founder mutation of moyamoya disease (MMD), is estimated to be only 1/150-1/300. However, the factors affecting its penetrance remain unclear....
2.
Wang Y, Zou Z, Yang Z, Zhang Z, Xu J, Hao F, et al.
Genes Dis
. 2024 Mar;
11(4):101090.
PMID: 38450100
No abstract available.
3.
Hao F, Han C, Lu M, Wang Y, Gao G, Wang Q, et al.
Eur Radiol
. 2024 Jan;
34(8):5179-5189.
PMID: 38172442
Objectives: Intracranial vessel wall enhancement (VWE) on high-resolution magnetic resonance imaging (HRMRI) is associated with the progression and poor prognosis of moyamoya disease (MMD). This study assessed potential risk factors...
4.
Bin P, Liu W, Zhang X, Liu B, Zhu G
Int J Antimicrob Agents
. 2023 Dec;
63(2):107057.
PMID: 38072168
Bacterial pathogens reprogramme their metabolic networks to support growth and establish infection at specific sites. Bacterial central metabolism has been considered attractive for developing antimicrobial drugs; however, most metabolic enzymes...
5.
Wang X, Liang M, Zeng F, Wang Y, Yang Y, Nie F, et al.
BMJ Open
. 2022 Jun;
12(6):e056680.
PMID: 35710238
Background: A growing number of meta-analyses reviewed the existing associations between modifiable factors and stroke. However, the methodological quality of them and quality of evidence remain to be assessed by...
6.
Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, et al.
Lancet Neurol
. 2022 May;
21(8):747-758.
PMID: 35605621
Moyamoya disease is a rare cause of stroke, radiologically characterised by progressive stenosis of the terminal portion of the internal carotid arteries and compensatory capillary collaterals. The discovery that RNF213,...
7.
Ta N, Liu M, Wang Y, Zeng F, Nie F, Shang M, et al.
Rev Cardiovasc Med
. 2021 Sep;
22(3):895-901.
PMID: 34565088
Hypertension is a complex disease which is mainly influenced by genetic factors. Recently, genome-wide association study (GWAS) found three novel endothelial dysfunction-related sites: Vascular endothelial growth factor A () rs9472135,...
8.
Wang Y, Zhang Z, Wang X, Zou Z, Ta N, Hao F, et al.
J Stroke Cerebrovasc Dis
. 2021 Sep;
30(11):106071.
PMID: 34482123
Objective: To validate, update, and extend the role of RNF213 p.R4810K (G>A) for predicting the phenotype of moyamoya disease (MMD) patients and explore the different effects on pediatric and adult...
9.
Wang X, Zhang Z, Wang Y, Zou Z, Ta N, Hao F, et al.
J Stroke Cerebrovasc Dis
. 2021 May;
30(7):105847.
PMID: 33992965
Objectives: This retrospective study was conducted to analyze the associations between ring finger protein 213 p.R4810K variant, clinical features and long-term outcomes in patients with moyamoya disease (MMD) after encephaloduroarteriosynangiosis...
10.
Wang Y, Yang L, Wang X, Zeng F, Zhang K, Zhang Q, et al.
Eur J Neurol
. 2020 Nov;
28(3):823-836.
PMID: 33175469
Background And Purpose: The aim of this meta-analysis study was to assess the predictive effects of RNF213 p.R4810K on phenotype in moyamoya disease (MMD). Methods: Electronic databases (e.g., Pubmed and...